IH05 - Safeguarding the Future of Biopharmaceutical Innovation: Biorepository and Stability Storage Solutions for Sustainable Drug Development (Exhibition Hall)

About this session

The journey from drug discovery to market approval is complex and it’s evolving rapidly, with 10,000–20,000 candidate drugs narrowed down to just one successful therapy. Alongside scientific and regulatory hurdles, the industry now faces sustainability challenges, requiring smarter approaches to formulation stability, compliance, and operational efficiency.
Join Astoriom’s Innovation Hub session to discover how biorepository and stability storage solutions are playing a critical role while organisations work towards Net Zero goals.

Key Takeaways

- Supporting R&D & Drug Discovery: Enhancing efficiency across the drug discovery process

- Regulatory Readiness: Developing new formulations while navigating evolving ECHA, EU REACH, HTA, FDA and MHRA compliance

- Formulation Stability & Risk Mitigation: Best practises to prevent sample degradation and ensuring regulatory success

- CapEx vs. OpEx Considerations: How to optimise investment in storage for long-term sustainability

- The Road to Net Zero – Exploring the role of sustainable storage solutions in reducing the biopharma industry’s carbon footprint

Who Should Attend?
R&D leaders, innovation teams, quality assurance professionals, project managers, directors and planning and sustainability officers looking to stay ahead of compliance and future-proof the sustainability of their scientific assets.

Speaker

• WC

  Wendy Cullen

  Business Development and Accounts Manager · Astoriom

  Speaker